Phase Ib/II study of capecitabine 7/7 schedule with neratinib in patients with HER2-positive metastatic breast cancer (MBC) Meeting Abstract


Authors: Wang, R.; Singh, J.; Sterlin, V.; Goldstein, M.; Lake, D.; Wong, S.; Baselga, J.; Norton, L.; Dang, C.
Abstract Title: Phase Ib/II study of capecitabine 7/7 schedule with neratinib in patients with HER2-positive metastatic breast cancer (MBC)
Meeting Title: 41st Annual San Antonio Breast Cancer Symposium (SABCS)
Journal Title: Cancer Research
Volume: 79
Issue: 4 Suppl.
Meeting Dates: 2018 Dec 4-10
Meeting Location: San Antonio, TX
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2019-02-01
Language: English
ACCESSION: WOS:000478677002332
DOI: 10.1158/1538-7445.Sabcs18-p6-18-30
PROVIDER: wos
Notes: Meeting Abstract: P6-18-30 -- Source: Wos
Altmetric Score
MSK Authors
  1. Larry Norton
    616 Norton
  2. Chau Dang
    176 Dang
  3. Diana E Lake
    74 Lake
  4. Rui Wang
    11 Wang
  5. Jose T Baselga
    438 Baselga
  6. Jasmeet Chadha Singh
    13 Singh
  7. Serena T Wong
    3 Wong